Expand INSM Menu
INSM MENU

INSM Latest Press Releases

-- September 4, 2026 --

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PRNewswire 7:01 AM

-- September 3, 2026 --

Insmed to Present Data Across Its Respiratory Portfolio, Including New Late-Breaking ARIKAYCE (amikacin liposome inhalation suspension) Results From Phase 3b ENCORE Study at the European Respiratory Society Congress 2026 PRNewswire 7:00 AM

-- August 26, 2026 --

Insmed to Present at September 2026 Investor Conferences PRNewswire 7:00 AM

-- August 24, 2026 --

BRINSUPRI (brensocatib) Approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients With Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease PRNewswire 7:00 AM

-- August 6, 2026 --

Insmed Reports Second-Quarter 2026 Financial Results and Provides Business Update PRNewswire 7:01 AM

-- July 23, 2026 --

Insmed to Host Second-Quarter 2026 Financial Results Conference Call on Thursday, August 6, 2026 PRNewswire 7:39 AM

-- July 16, 2026 --

Insmed Announces Positive 12-Month Data from the Ongoing Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Patients with Pulmonary Arterial Hypertension PRNewswire 7:00 AM

-- June 30, 2026 --

Palvella Therapeutics Appoints Accomplished Rare Disease Biotech Executive and Commercial Leader Matt Pauls, J.D., M.B.A., to Board of Directors Globe Newswire 7:30 AM

-- June 23, 2026 --

Insmed Appoints Samuele Butera as Senior Vice President, General Manager, Global Respiratory PRNewswire 7:01 AM

-- June 11, 2026 --

Nasdaq-100 Index June 2026 Quarterly Changes Globe Newswire 8:00 PM

-- June 4, 2026 --

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PRNewswire 7:00 AM

-- May 27, 2026 --

Insmed to Present at the 2026 Goldman Sachs Annual Global Healthcare Conference PRNewswire 7:00 AM

-- May 7, 2026 --

Insmed Reports First-Quarter 2026 Financial Results and Provides Business Update PRNewswire 7:00 AM

-- May 4, 2026 --

Insmed to Present Data Across Its Respiratory Portfolio, Including Late-Breaking ARIKAYCE Results from Phase 3b ENCORE Study, at the American Thoracic Society International Conference 2026 PRNewswire 7:00 AM

-- April 30, 2026 --

Insmed to Present at May 2026 Investor Conferences PRNewswire 7:00 AM

-- April 23, 2026 --

Insmed to Host First-Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026 PRNewswire 7:00 AM
Market Data Delayed 15 Minutes